Literature DB >> 24484761

Words of wisdom: Re: Pazopanib versus sunitinib in metastatic renal-cell carcinoma.

Idir Ouzaid1, Brian Rini2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24484761     DOI： 10.1016/j.eururo.2013.11.023

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms.

Authors:  C Rothermundt; J von Rappard; T Eisen; B Escudier; V Grünwald; J Larkin; D McDermott; J Oldenburg; C Porta; B Rini; M Schmidinger; C N Sternberg; P M Putora
Journal:  World J Urol       Date:  2016-08-03       Impact factor: 4.226

Review 2.  Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma.

Authors:  David M Gill; Andrew W Hahn; Peter Hale; Benjamin L Maughan
Journal:  Curr Treat Options Oncol       Date:  2018-01-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.